pocketful logo
Sandu Pharmaceuticals Ltd logo

Sandu Pharmaceuticals Ltd

NSE: BSE: 524703

₹35

(-1.07%)

Tue, 10 Mar 2026, 11:42 pm

mtf coin illustrationMTF 5x

Sandu Pharmaceuticals Enterprise Value (EV)

D/EEVEV/EBITDAP/BP/CFP/EP/SROE %
Particulars20082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio6.3113.6810.7921.5410.9114.1737.9332.4352.9236.2723.0711.5520.7337.6432.3837.9430.50
Price to book ratio0.370.610.540.610.490.390.860.930.820.720.540.280.761.701.291.371.13
Price to sales ratio0.380.610.410.380.290.200.410.450.520.410.310.170.390.910.750.820.70
Price to cash flow ratio48.128.839.4902.4504.4506.54728.445.641.442.9564.95164.4064.7649.53
Enterprise value81.26M111.01M100.77M134.94M133.57M155.02M238.69M281.49M303.48M282.97M208.17M80.24M110.1M556.47M469.43M543.01M451.54M
Enterprise value to EBITDA ratio5.097.126.037.306.887.2410.599.8016.2711.429.785.505.1219.3518.8823.6516.33
Debt to equity ratio0.190.190.170.240.480.550.690.610.390.340.210.0400000.01
Return on equity %04.555.132.924.532.782.282.92-1.932.382.352.483.484.544.023.663.76

Sandu Pharmaceuticals Ltd Enterprise Value

The Sandu Pharmaceuticals Ltd Enterprise Value is a key financial metric used by investors to evaluate Sandu Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Sandu Pharmaceuticals Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Sandu Pharmaceuticals Ltd (NSE: , BSE: 524703) is currently trading at ₹35, with a market capitalization of ₹338.13M. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Sandu Pharmaceuticals Ltd Enterprise Value is essential for fundamental analysis.

Sandu Pharmaceuticals Ltd Enterprise Value Current Value

The current Sandu Pharmaceuticals Ltd Enterprise Value stands at 451.54M.

The Sandu Pharmaceuticals Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Sandu Pharmaceuticals Ltd Enterprise Value Historical Trend

The Sandu Pharmaceuticals Ltd Enterprise Value has shown the following historical trend:

  • 2024: 451.54M
  • 2023: 543.01M
  • 2022: 469.43M
  • 2021: 556.47M
  • 2020: 110.1M

The decline in Sandu Pharmaceuticals Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Sandu Pharmaceuticals Ltd Enterprise Value Indicates for Investors

The Sandu Pharmaceuticals Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Ltd Enterprise Value Analysis Summary

The Sandu Pharmaceuticals Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sandu Pharmaceuticals Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Sandu Pharmaceuticals Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800